Point-of-care assays demonstrate resistance to clopidogrel, but not aspirin, in patients with previous Stent Thrombosis

被引：0
|
作者：
Hobson, Alex R. [1 ]
Morton, Geraint [2 ]
Petley, Graham [3 ]
Dawkins, Keith D. [1 ]
Curzen, Nick P. [1 ]
机构：
[1] Wessex Cardiac Unit, Southampton, Hants, England
[2] N Hampshire Hosp, Basingstoke, Hants, England
[3] Southampton Univ Hosp, Dept Med Phys & Bioengn, Southampton, Hants, England
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2007年 / 100卷 / 8A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：195L / 195L
页数：1
相关论文
共 50 条
  • [1] Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapy
    Hobson A.R.
    Petley G.
    Morton G.
    Dawkins K.D.
    Curzen N.P.
    Thrombosis Journal, 6 (1)
  • [2] Clopidogrel resistance and aspirin resistance - A cause of coronary artery stent thrombosis?
    Klamroth, R
    Hoffmann, S
    Andresen, D
    Landgraf, H
    BLOOD, 2004, 104 (11) : 104B - 104B
  • [3] Platelet Response to Clopidogrel Assessed With Point-of-Care Analysis and Drug-Eluting Stent Thrombosis
    Sibbing, Dirk
    Braun, Siegmund
    Morath, Tanja
    Mehilli, Julinda
    Vogt, Wolfgang
    Schomig, Albert
    Kastrati, Adnan
    von Beckerath, Nicolas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A1 - A2
  • [4] Recurrent coronary stent thrombosis in a patient with combined aspirin and clopidogrel resistance
    Templin, C
    Schaefer, A
    Stumme, B
    Drexler, H
    Prondzinski, MV
    35th Hemophilia Symposium, 2006, : 235 - 238
  • [5] Combined aspirin and Clopidogrel resistance associated with recurrent coronary stent thrombosis
    Templin C.
    Schaefer A.
    Stumme B.
    Drexler H.
    Von Depka M.
    Clinical Research in Cardiology, 2006, 95 (2) : 122 - 126
  • [6] Measurement of clopidogrel inhibition with a point-of-care assay identifies patients at risk for stent thrombosis after percutaneous coronary intervention
    Price, Matthew J.
    Wong, Garrett B.
    Valencia, Rafael
    Lee, Steve S.
    Gollapdui, Raghava
    Teirstein, Paul S.
    CIRCULATION, 2006, 114 (18) : 452 - 452
  • [7] Measurement of clopidogrel inhibition with a point-of-care assay identifies patients at risk for stent thrombosis after percutaneous coronary intervention
    Price, Matthew J.
    Wong, Garrett B.
    Valencia, Rafael
    Lee, Steve S.
    Gollapudi, Raghava
    Teirstein, Paid S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 204M - 204M
  • [8] Comparison of two point-of-care assays for clopidogrel responsiveness of platelets
    Breugelmans, Jaimie
    Vertessen, Francine
    Mertens, Gerhard
    Van der Planken, Marc
    ACTA CLINICA BELGICA, 2009, 64 (02): : 182 - 182
  • [9] Prevalence of Aspirin and Clopidogrel Resistance Among Patients With and Without Drug-Eluting Stent Thrombosis
    Slottow, Tina L. Pinto
    Bonello, Laurent
    Gavini, Rekha
    Beauzile, Patricia
    Sushinsky, Steven J.
    Scheinowitz, Mickey
    Kaneshige, Kimberly
    Xue, Zhenyi
    Torguson, Rebecca
    Tantry, Udaya
    Pichard, Augusto D.
    Satler, Lowell F.
    Suddath, William O.
    Kent, Kenneth
    Gurbel, Paul
    Waksman, Ron
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (04): : 525 - 530
  • [10] Incidence of aspirin and clopidogrel resistance in Korean patients with coronary artery disease determined by the point-of-care system VerifyNow.
    Kim, S. Y.
    Suh, J. W.
    Lee, H. Y.
    Kang, H. J.
    Koo, B. K.
    Kim, H. S.
    Sohn, D. W.
    Oh, B. H.
    Park, Y. B.
    Choi, Y. S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (08): : 92F - 92F
12345